Global EditionASIA 中文双语Français
Home / Business / Latest

Multinational firm execs laud Xi's keynote remarks at CIIE

By Zhou Wenting, He Wei, Xing Yi, Zhong Nan, Ma Si, Wang Zhuoqiong, Zheng Yiran and Shi Jing | | Updated: 2020-11-05 01:18
Share - WeChat
Cecilia Qi, Vice President, General Manager of Pharma and Vaccines, GSK China

CIIE is an important window for China to share market opportunities with the world under the "dual circulation" strategy. It provides China with a platform to embrace openness and showcase innovative results, and also brings opportunities for mutual benefits and inclusiveness to the world.

GSK has a history in China for over a century with a constant commitment to helping improve the health, life and future of Chinese people.

In the future, we will further leverage our advantages and expertise in the fields of pharmaceuticals and vaccines, continue to expand our business in China, step up efforts to introduce innovative healthcare solutions, and continuously improve the accessibility of high-quality medical resources. We aim to enable high-quality innovative healthcare solutions to benefit more Chinese people and contribute to the Healthy China Initiative.

|<< Previous 1 2 3 4 5 6 7 8 9 10 11 12   
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349